Lapatinib in Stage IV Melanoma With ERBB4 Mutations
 
Sponsors and Collaborators

National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
 
Contact
NCI Referral Office
1-888-NCI-1937
 
ClinicalTrials.gov Identifier
NCT01264081